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Background: Early identification of pathogens and antimicrobial resistance in bloodstream infections (BSIs)
decreases morbidity and mortality, particularly in immunocompromised patients. The aim of the present study was
to compare real-time polymerase chain reaction (PCR) with commercial kits for detection of 17 pathogens from
blood culture (BC) and 10 antimicrobial resistance genes.
Methods: A total of 160 BCs were taken from bone marrow transplant patients and screened with Gram-specific
probes by multiplex real-time PCR and 17 genus-specific sequences using TaqMan probes and blaSHV, blaTEM,
blaCTX, blaKPC, blaIMP, blaSPM, blaVIM, vanA, vanB, and mecA genes by SYBR Green.
Results: Twenty-three of 33 samples identified by phenotypic testing were concordantly positive by BC and real-time
PCR. Pathogen identification was discordant in 13 cases. In 12 of 15 coagulase-negative staphylococci, the mecA gene
was detected and four Enterococcus spp. were positive for vanA. Two blaCTX and three blaSHV genes were found by
quantitative PCR. The blaKPC and metallo-β-lactamase genes were not detected. Five fungal species were identified
only by real-time PCR.
Conclusions: Real-time PCR could be a valuable complementary tool in the management of BSI in bone marrow
transplants patients, allowing identification of pathogens and antimicrobial resistance genes.
Keywords: Bone marrow transplants, Real-time polymerase chain reaction, Antibiotic resistance genes, Bloodstream
infectionsBackground
Approximately 60% of episodes of fever in patients with
neutropenia are frequently correlated with documented
bloodstream infection (BSI). BSI is associated with high
morbidity and a mortality rate ranging from 20 to 70%.
The SENTRY Antimicrobial Surveillance Program (1997–
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reproduction in any medium, provided the or89–92% of all isolates in 659,935 cases of sepsis reported in
the United States in 2000. The ranking of microorganisms
was similar across North America, Latin America, and
Europe [1]. The rank of the five major pathogens in the
Brazilian SCOPE (Surveillance and Control of Pathogens
of Epidemiological Importance) were Staphylococcus
aureus (15.4%), coagulase-negative staphylococci (CoNS)
(13.4%), Klebsiella spp. (13.2%), Acinetobacter spp. (12.5%),
and Pseudomonas aeruginosa (8.9%) [2].
The most dangerous clinical manifestations of BSI are
sepsis and shock, which are the 10th leading cause of
death in the United States, accounting for 6% of all
deaths (50.37 deaths per 100,000 individuals in theal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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provision of appropriate antimicrobial therapy correlate
with positive clinical outcomes [4]. Blood culture (BC) is
considered to be the gold standard for detecting micro-
organisms in the bloodstream, including those that have
antibiotic resistance genes [5]. Molecular amplification
techniques have been used to detect microorganisms in
BSI. Automated BC systems take 1–2 days, on average,
to signal a positive result and a further 1–2 days to
finalize bacterial identification and antimicrobial testing.
Rapid detection of bacterial resistance mechanisms in
BC bottles can assist physicians with both patient ma-
nagement and infection control.
Methods
Patients
During October 2008 to July 2011, 160 BCs from Bactec
bottles were analyzed from 33 immunocompromised pa-
tients (31 adults and two children) with hematological ma-
lignancies who underwent bone marrow transplantation
(seven acute myeloid leukemia, six multiple myeloma, six
non-Hodgkin’s lymphoma, four acute lymphoblastic
leukemia, two Hodgkin’s disease, two chronic myeloproli-
ferative disorders, one chronic lymphoblastic leukemia,
one adenovirus dystrophia, one Ewing syndrome, one pi-
neal carcinoma and one testicular cancer). Patients were
admitted to the Institute of Pediatric Oncology (GRAACC)
and the Adult Hematology Unit of São Paulo Hospital,
Federal University of São Paulo, Brazil. Informed consent
was obtained from patients and the study was approved
by the Clinical Research Ethics Committee of the hospital.
Sample collection and bacterial identification
The samples were collected as part of standard patient
care from patients suspected of BSI in the pretransplant
mobilization phase of hematopoietic stem cell trans-
plantation, transplanted patients, and patients admitted
with clinical complications after transplantation. At the
onset of fever (>37°C) or in the presence of any clinical
symptom compatible with infection, two sets of BCs were
taken. BSI was defined as the isolation of a bacterial or
fungal pathogen from at least one BC. For CoNS, coryne-
bacteria other than Corynebacterium jeikeium and com-
mon skin contaminants, at least two sets of positive BCs
were required. All episodes of BSI were then subclassified
as single-agent (Gram-positive, Gram-negative or fungal)
or polymicrobial. For polymicrobial BSI, two or more
pathogens were isolated from a single BC or at least two
separate BCs at 96 h apart. BCs were performed using
the Bactec 9240 (Becton Dickinson, Microbiology Sys-
tems, Cockeysville, MD, USA). BC bottles were signaled
positive by Bactec 9240 after detection of bacterial
growth. The samples were negative by Bactec when no
bacterial growth was detected after 5 days incubation.Identification to species level and susceptibility testing
were performed using the automated system Phoenix
100 (Becton Dickinson Microbiology Systems).
DNA extraction
Total DNA was extracted from the positive or negative
500-μl BC broth after incubation on Bactec 9240, using the
phenol–chloroform method (Brazol; LGC Biotechnologia,
Cotia, Brazil) with 300 mg glass beads (0.3 mm diameter;
Scientific Industries, Bohemia, NY, USA) and processed in
a disruptor Genie (Scientific Industries) for 10 min to
achieve cell lysis.
Primers and TaqMan probe
The primers used for detection of the resistance genes,
blaSHV, blaTEM, blaCTX-M, blaIMP, blaSPM, blaVIM,
blaKPC, vanA, vanB and mecA, have been described
previously [6]. The TaqMan probes for multiplex real-
time polymerase chain reaction (PCR) detection of
Gram-positive and Gram-negative bacteria have been
previously described, as well as species-specific TaqMan
probes for detection of Enterococcus spp., CoNS, S.
aureus, Streptococcus pneumoniae, Escherichia coli, Kleb-
siella pneumoniae, Enterobacter cloacae, Proteus mirabilis,
Salmonella spp., Serratia marcescens, Acinetobacter
baumannii, P. aeruginosa, Stenotrophomonas maltophilia,
Mycobacterium tuberculosis, Aspergillus spp., Candida
spp. and Fusarium spp. [7]. All the primers and probes
were selected from the National Center for Biotechnology
Information website (NCBI; http://www.ncbi.nlm.nih.gov)
and synthesized by Applied Biosystems (Foster City, CA,
USA). The primers were checked for specificity in a
BLAST search available through the NCBI website
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). A primer set
for the hemochromatosis gene was designed to be used
as an internal control.
Real-time PCR
Detection of bacterial DNA was screened using universal
primers of 16S rDNA gene. Differentiation between
Gram-positive and Gram-negative bacteria was done by
TaqMan multiplex real-time PCR [7]. Differentiation of
the other genes was performed by monoplex real-time
PCR. Amplification for TaqMan probes reactions was
performed in a 20-μl reaction volume, using 10 μl
TaqMan Universal Master Mix 2X (Applied Biosystems),
5 μl template DNA, 0.5 μM each primer, and 0.3 μM
probe. The real-time PCR conditions were as follows:
50°C for 2 min and 95°C for 10 min; 40 cycles of 95°C
for 15 s and 60°C for 60 s. Resistance genes amplification
by SYBR Green monoplex real-time PCR was performed
in a 25-μl reaction mixture containing 12.5 μl Platinum
SYBR Green qPCR SuperMix (Invitrogen, Carlsbad, CA,
USA), 0.5 μM each primer, and 5 μl purified DNA
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were as follows: 50°C for 2 min and 95°C for 10 min;
40 cycles of 95°C for 15 s and 60°C for 60 s; and a
melting curve step (from 68°C to 95°C in increments
of 0.5°C/s). The metallo-β-lactamase amplification was
performed by multiplex real-time PCR [7]. The ABI
7500 real-time PCR System (Applied Biosystems) in-
strument was quantified online and at the endpoint
with the sequence detection system software (version
2.0; Applied Biosystems).
Data analysis
Data collection and statistical analysis were performed
using SSPS version 17.0 software (SPSS Inc., Chicago,
IL, USA) and Microsoft Office Excel 2007 (Microsoft,
Redmond, WA, USA). The area under the receiver oper-
ating characteristic curve (AUC) was determined for
binary diagnostic test results for all genes. Comparison
of the BC identification by Phoenix versus real-time
PCR results were evaluated by χ2 tests. Discordance be-
tween the results from the two methods was assessed
using McNemar’s test (statistical significance was set at a
two-tailed exact test, based on the binomial distribution
with p = q = 0.5). The κ statistic was calculated to meas-
ure the level of agreement between BC by Phoenix and
real-time PCR results.
Results
Sample collection and bacterial identification
A total of 160 blood samples collected from 33 patients
were evaluated for BSI. Thirty-three samples, repre-
senting 15 febrile episodes, tested positive by BC. BC
identified 23 Gram-positive bacteria (15 CoNS, four En-
terococcus faecium, two Enterococcus faecalis and two
Str. pneumoniae) and 10 Gram-negative bacteria [one
Pseudomonas putida, two Acinetobacter spp., three Ent.
cloacae, one K. pneumoniae, one E. coli, one non-
fermenting Gram-negative bacilli (NFGNB) and one
Citrobacter freundii].
Real-time PCR
Real-time PCR detected 37 positive samples (Table 1).
The data for negative samples by the two methods are
not shown. Twenty-three of 33 samples identified by
phenotypic testing were concordantly positive by BC
and real-time PCR (Table 1). Twenty-one samples were
discordant by both methods. Nine BC-positive samples
were negative by real-time PCR and 12 BC-negative
samples were positive by PCR.
Table 1 shows only positive samples that were isolated
by BC and/or real-time PCR. The other 21 negative re-
sults are not shown.
For Gram-positive bacteria, 15 CoNS were positive by
BC and 13 of these were detected by real-time PCR.Three CoNS were detected by real-time PCR but did not
grow in culture. Three of six BCs that were positive for
Enterococcus spp. were negative by real-time PCR, while
whereas BC did not detect one sample that was positive
by real-time PCR. In two samples, BC identified Str.
Pneumoniae, while real-time PCR was not positive for
one of these samples.
For Gram-negative bacteria, all Ent. cloacae and E. coli
samples were concordant by both methods (Table 1). In
three samples, growth of C. freundii, Acinetobacter spp.
and P. putida was detected by BC and by Gram-
negative probe; however, specific primers and probes
were not designed for these pathogens, therefore they
were not considered discrepant. Two samples were
positive for K. pneumoniae by real-time PCR and nega-
tive by BC, whereas one BC-positive sample was
negative by real-time PCR. Three samples were identi-
fied as A. baumannii by real-time PCR and one of these
was positive by BC, one was BC-positive for NFGNB,
and one was not detected by BC.
The overall concordance level was 72.7% for pheno-
typic and real-time PCR methods with a Cohen κ coeffi-
cient of 0.7 (95% CI: 0.61–0.80).
For resistance genes, real-time PCR detected 12 CoNS
with mecA genes. Nine samples were concordant for
detection of the mecA gene compared with phenotypic
resistance to methicillin. The vanA gene was detected in
four Enterococcus spp. (Enter. faecalis and Enter. faecium)
and none were positive for the vanB gene. The concord-
ance was 100% between two vancomycin resistance
methods (Table 1).
For Gram-negative bacteria, five samples detected the
ESβL gene by real-time PCR. The blaSHV gene was
detected in three samples and blaCTX-M in two
(Table 1). Only two of the five positive ESβL real-time
PCR samples were identified by the phenotypic method
as ESβL producers; the other two were identified as
ESβL producers by the phenotypic method but were
negative by real-time PCR (Table 1).
The blaKPC and metallo-β-lactamase genes were not
detected. The A. baumannii samples showed carbapenem
phenotypic resistance; however, the carbapenemase genes
were not detected.
Three Candida spp. were detected from two patients
by real-time PCR but not by BC. In one patient, two
samples were positive by real-time PCR. Two samples
were positive for Aspergillus spp. by real-time PCR with
negative galactomannan antigenemia. Fusarium spp.
were not detected.
Real-time PCR performance for bacterial identification
was adjusted as follows: sensitivity, 78%; specificity, 93%;
negative predictive value (NPV), 95%; positive predictive
value (PPV), 72% when compared with the phenotypic
method.




BactecW Results Bacterial isolated from
blood culture (PhoenixW)
Bacterial detected





10/9/2009 Positive S. epidermidis CoNS S* Oxacilin mecA
10/9/2009 Positive S. epidermidis CoNS S Oxacilin mecA
10/9/2009 Positive S. epidermidis CoNS S Oxacilin mecA
Cephalosporins
01
12/20/2009 Positive C.freundii CoNS S and ND
Carbapenems
12/20/2009 Positive S. epidermidis CoNS R* Oxacilin mecA
3/1/2009 Negative ND CoNS and GN NA NA blaSHV
1/9/2010 Negative ND Aspergillus spp. NA NA NA
12/4/2008 Positive E. cloacae E. cloacae R Cephalosporins ND
02
12/4/2008 Positive E. cloacae E. cloacae R Cephalosporins ND
12/4/2008 Positive E. cloacae E. cloacae R Cephalosporins blaSHV
3/5/2009 Positive CoNS CoNS R Oxacilin mecA
03
3/5/2009 Positive CoNS CoNS R Oxacilin mecA
3/5/2009 Positive CoNS CoNS R Oxacilin ND
5/8/2009 Positive P. putida ND NA NA ND
04
5/8/2009 Positive S. epidermidis CoNS R Oxacilin mecA
5/8/2009 Positive S. epidermidis CoNS R Oxacilin mecA
05
8/2/2009 Positive S. pneumoniae ND S Penicilin ND
8/2/2009 Positive S. pneumoniae S. pneumoniae S Penicilin ND
6/6/2009 Positive E. faecium Enterococcus spp. R Glycopeptide vanA
06
6/6/2009 Positive E. faecium ND R Glycopeptide vanA
6/6/2009 Positive E. faecium ND R Glycopeptide vanA
07




1/31/2009 Positive Acinetobacter spp. ND R and ND
Carbapenems
1/31/2009 Negative ND A. baumannii NA NA ND
R Cephalosporins
08
3/2/2009 Positive K. pneumoniae ND and and ND
S Carbapenems
09
9/28/2009 Positive E. faecalis ND S Glycopeptide ND
9/28/2009 Positive E. faecalis Enterococcus spp. S Glycopeptide ND
10
12/12/2008 Positive E. faecium Enterococcus spp. R Glycopeptide vanA
12/9/2008 Negative ND Enterococcus spp. NA NA ND
11
12/18/2008 Negative ND K. pneumoniae NA NA blaCTX-M
12/21/2008 Negative ND K. pneumoniae NA NA blaCTX-M
2/21/2009 Negative ND CoNS and GN NA NA ND
28/03/2011 Negative ND CoNS NA NA ND
2/21/2009 Negative ND Candida spp. NA NA NA
12
4/8/2011 Positive S. epidermidis CoNS R Oxacilin mecA
4/8/2011 Positive S. epidermidis CoNS R Oxacilin mecA
4/8/2011 Positive S. epidermidis CoNS R Oxacilin mecA
13 3/14/2009 Negative ND ND NA NA blaSHV
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Table 1 Results of real-time PCR, culture identification and antimicrobial susceptibility of positive samples from BC
bottles (Continued)
14 11/4/2010 Positive A. baumannii A. baumannii S Cephalosporins ND
15
3/26/2011 Positive E. coli E. coli S Cephalosporins and
Carbapenems
ND
16 3/31/2011 Positive S. epidermidis CoNS R Oxacilin mecA
17
5/8/2009 Positive CoNS ND R Oxacilin ND
5/8/2009 Positive CoNS ND R Oxacilin ND
18 5/14/2009 Negative ND Aspergillus spp. NA NA NA
19
5/2/2009 Negative ND Candida albicans NA NA NA
5/4/2009 Negative ND Candida albicans NA NA NA
R: Resistant; S: Susceptible; * CLSI 2010; NA: results not available; ND: Not Detected.
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Early identification of the causative pathogen in BSI is
crucial, especially in transplant patients, and can im-
prove survival in the post-transplant period. In addition,
rapid detection of resistance genes in the bloodstream
can contribute to the efficacy of antimicrobial treatment
with reduced morbidity/mortality [8-10].
The use of PCR for diagnostic purposes has established
a new era in the detection and characterization of micro-
organisms directly from clinical samples. Several protocols
based on PCR amplification of 16S rDNA for differen-
tiation of Gram-positive and Gram-negative bacteria have
been used with samples collected from different infectious
sites [11,12].
Commercially available multiplex real-time PCR assay
kits have been evaluated in adult patients with hema-
tological malignancies and compared with BC for iden-
tification of microorganisms [13]. Our study reports the
clinical application of real-time PCR for identification of
bacteria and detection of antibiotic resistance genes in adult
and pediatric patients with hematological malignancies.
The PCR showed nine negative results that tested posi-
tive by BC and 12 that were positive by real-time PCR and
negative by BC. The negative real-time PCR results that
were positive by BC failed to show frequent bloodstream
pathogens such as CoNS, enterococci, streptococci and K.
pneumoniae. Varani et al. have reported positive BC re-
sults for CoNS and Streptococcus mitis, which were not
detected by real-time PCR [14]. Louie et al. have detected
positive BC for Enter. Faecalis, whereas real-time PCR
failed to identify this microorganism [15]. This difference
allowed us to establish a limit of detection (LoD) to distin-
guish between infection and contamination. The low sen-
sitivity of real-time PCR for CoNS, Enterococcus spp. and
Str. pneumoniae was possibly associated with the Ct and
LoD. Ct specifically sets analytical cutoff values to distin-
guish contamination from infection in bone marrow
transplant patients. Lehmann et al. have reported the im-
portance of determining cutoff values to discriminate be-
tween significant bacterial loads in clinical samples andlow amounts of bacterial DNA [16]. In addition, the pre-
sence of a high bacterial DNA concentration might inhibit
molecular detection [17].
In samples in which bacteria were only detected with
real-time PCR, the microorganisms detected were one A.
baumannii, two K. pneumoniae, one Enterococcus spp.
and three CoNS (Table 1). Varani et al. have detected
Gram-negative bacteria more than BC and Enterococcus
spp. did not grow in culture [14]. Louie et al. have ob-
served 17 cases in which PCR identified an organism that
was not found by BC [15]. The previous use of antibiotics
that is common in our patient population, including
antibiotic prophylaxis, could contribute for these cases
of bacteria only detected with real time PCR. Our cases
that were positive for K. pneumoniae and A. baumannii
showed genuine bacterial recovery because 19 days after
PCR, K. pneumoniae was detected in another culture
that was not available for real-time PCR. Others have
suggested that the detection of circulating bacterial
DNA and the presence of nonviable bacterial DNA
detected by real-time PCR could be considered as con-
taminants [16,18].
The real-time PCR detected Candida DNA in three
samples from two patients with probable or possible
BSI, whereas BC showed negative results. Differences
among BC systems for detection of Candida spp. do not
explain the disagreement with the real-time PCR [19,20].
Mancini et al. have detected Aspergillus spp. in blood
samples by LightCycler SeptiFast (Roche Diagnostics,
GmbH, Mannheim, Germany) [13]. The identification by
real-time PCR was consistent with the presence of
nonviable fungal components or of very low viable fun-
gal loads [21,22].
The aim of our study was to detect 10 resistance
genes. We found samples with blaSHV, blaCTX-M,
vanA, and mecA genes by real-time PCR. Identification
of these genes, together with clinical context, could be
an important tool to help with the management of the
appropriate therapy. One of the limitations of commer-
cial kits for identifying bacteria and fungi in blood using
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terns and resistance genes [14]. In our study, real-time
PCR did not detect all the resistance genes; therefore,
real-time PCR does not replace conventional bacteri-
ology for antimicrobial agents.
The nonexistence of a gold standard regular diagnostic
procedure is a major limitation for the evaluation of new
molecular techniques. The positive BC results due to
contamination represent a limitation for the interpret-
ation of positive or negative real-time PCR results [23].
Karahan et al. have reported false-positive BC results that
were suggestive of the presence of microbial DNA [24].
Accordingly, a negative result by real-time PCR cannot ex-
clude the presence of BSI in neutropenic patients, and Pe-
ters et al. and Nakamura et al. have recommended that
interpretation of real-time PCR results should conform to
the clinical context [23,25].Conclusion
BC remains the gold standard for microbial diagnostics.
However, real-time PCR could also be a valuable tool.
Every effort should be made to improve the yield of this
new diagnostic modality, particularly in critically ill
patients. The results obtained should be interpreted to-
gether with clinical and other laboratory data. A large
controlled study is in progress to evaluate further the
clinical benefits of using real-time PCR in this patient
setting.
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